DexCom (Brazil) Market Value
| D1EX34 Stock | BRL 8.00 0.20 2.44% |
| Symbol | DexCom |
DexCom 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to DexCom's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of DexCom.
| 12/18/2024 |
| 03/18/2025 |
If you would invest 0.00 in DexCom on December 18, 2024 and sell it all today you would earn a total of 0.00 from holding DexCom Inc or generate 0.0% return on investment in DexCom over 90 days. DexCom is related to or competes with Bemobi Mobile, Livetech, Ameriprise Financial, SVB Financial, Lupatech, HDFC Bank, and Cincinnati Financial. DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose ... More
DexCom Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure DexCom's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess DexCom Inc upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.08) | |||
| Maximum Drawdown | 15.13 | |||
| Value At Risk | (3.48) | |||
| Potential Upside | 5.62 |
DexCom Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for DexCom's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as DexCom's standard deviation. In reality, there are many statistical measures that can use DexCom historical prices to predict the future DexCom's volatility.| Risk Adjusted Performance | (0.09) | |||
| Jensen Alpha | (0.23) | |||
| Total Risk Alpha | (0.03) | |||
| Treynor Ratio | (0.54) |
DexCom Inc Backtested Returns
DexCom Inc secures Sharpe Ratio (or Efficiency) of -0.11, which denotes the company had a -0.11 % return per unit of risk over the last 3 months. DexCom Inc exposes twenty-one different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm DexCom's Mean Deviation of 1.48, variance of 5.79, and Standard Deviation of 2.41 to check the risk estimate we provide. The firm shows a Beta (market volatility) of 0.51, which means possible diversification benefits within a given portfolio. As returns on the market increase, DexCom's returns are expected to increase less than the market. However, during the bear market, the loss of holding DexCom is expected to be smaller as well. At this point, DexCom Inc has a negative expected return of -0.26%. Please make sure to confirm DexCom's potential upside, kurtosis, rate of daily change, as well as the relationship between the skewness and daily balance of power , to decide if DexCom Inc performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.58 |
Good reverse predictability
DexCom Inc has good reverse predictability. Overlapping area represents the amount of predictability between DexCom time series from 18th of December 2024 to 1st of February 2025 and 1st of February 2025 to 18th of March 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of DexCom Inc price movement. The serial correlation of -0.58 indicates that roughly 58.0% of current DexCom price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.58 | |
| Spearman Rank Test | -0.35 | |
| Residual Average | 0.0 | |
| Price Variance | 0.69 |
DexCom Inc lagged returns against current returns
Autocorrelation, which is DexCom stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting DexCom's stock expected returns. We can calculate the autocorrelation of DexCom returns to help us make a trade decision. For example, suppose you find that DexCom has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
DexCom regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If DexCom stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if DexCom stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in DexCom stock over time.
Current vs Lagged Prices |
| Timeline |
DexCom Lagged Returns
When evaluating DexCom's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of DexCom stock have on its future price. DexCom autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, DexCom autocorrelation shows the relationship between DexCom stock current value and its past values and can show if there is a momentum factor associated with investing in DexCom Inc.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Information and Resources on Investing in DexCom Stock
When determining whether DexCom Inc is a strong investment it is important to analyze DexCom's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact DexCom's future performance. For an informed investment choice regarding DexCom Stock, refer to the following important reports:Check out DexCom Correlation, DexCom Volatility and DexCom Alpha and Beta module to complement your research on DexCom. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
DexCom technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.